TotalMarketCap

Amgen

AMGNNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$249.176 B

$460.66 -3.72%

Close of 6 Nov 2026

As of 6 Nov 2026, Amgen (AMGN) has a market capitalization of $249.2B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$36.8B

#117 by revenue

Earnings

$7.71B

#61 by earnings

Shares outstanding

540,911,490

Latest filing cover page

P/E ratio

32.3

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #1AmgenAMGN$249.2B
  2. #2Gilead SciencesGILD$207.8B
  3. #3ModernaMRNA$96.5B
  4. #4Argenx SeARGX$55.8B
  5. #5Revolution MedicinesRVMD$38.5B

What if Amgen were worth as much as…

Open the what-if tool →

Gold $28.2T

$52,202.39

Per share 113× higher

Bitcoin $1.53T

$2,824.58

Per share 6.13× higher

Apple $5.02T

$9,272.83

Per share 20.1× higher

Or at a round number

$500.0B$1.00T$2.00T$5.00T

Where these numbers come from

Share counts and financials for Amgen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.